CN109303758A - A kind of preparation method of skin maintenance and cosmetic benefits freckle-diminishing capsule - Google Patents
A kind of preparation method of skin maintenance and cosmetic benefits freckle-diminishing capsule Download PDFInfo
- Publication number
- CN109303758A CN109303758A CN201811391289.9A CN201811391289A CN109303758A CN 109303758 A CN109303758 A CN 109303758A CN 201811391289 A CN201811391289 A CN 201811391289A CN 109303758 A CN109303758 A CN 109303758A
- Authority
- CN
- China
- Prior art keywords
- preparation
- follows
- water
- decoction
- volumes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Marine Sciences & Fisheries (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a kind of preparation methods of skin maintenance and cosmetic benefits freckle-diminishing capsule.The preparation method include the following steps: using ethanol water refluxing extraction root of kirilow rhodiola, the fleece-flower root and Radix Angelicae Sinensis mixture at least three times, combined extract, filtering, recycling ethyl alcohol obtain solution;Using the mixture of steam distillation processing safflower and azalea, volatile oil and the dregs of a decoction are obtained;The dregs of a decoction are merged with fructus lycii and Radix Astragali, are added water to cook at least three times, collecting decoction filters to get filtrate;(4) filtrate is merged with above-mentioned solution, is condensed into thick paste;By crushing pearl at pearl powder;Thick paste and pearl powder are mixed, then crushes after drying and obtains fine powder;Fine powder and volatile oil are mixed, are packed into capsule to obtain the final product.The present invention, instead of radix rehmanniae recen and Rehmannia glutinosa in original formulation, is used as medicine with safflower and Du Juan volatile oil with safflower and azalea, further shortens the drug effect time, and improve treated effect.
Description
Technical field
The present invention relates to a kind of preparation methods of skin maintenance and cosmetic benefits freckle-diminishing capsule, belong to cosmetic technical field.
Background technique
Chloasma is that the acquired irregular brown pigment of the face occurred is calm, it is considered that its with endocrine disturbance,
The factors such as solarization, mood are related, and disease incidence is in rising trend in recent years, and age of onset tends to rejuvenation.
This disease there is no the treatment method of special efficacy at present.Hydrochinone Cream, retinoid drug have certain effect, but there is also not
Foot: curative effect improves when Hydrochinone Cream high concentration, but irritation aggravates, and prolonged application can lead to exogenous chloasma;Vitamin A acid works
Slowly, need or so continuous medication half a year gradually effective.Brilliant pearl stonecrop spot removal capsule is selected from high crude drug, with root of kirilow rhodiola, Huang
The composition such as stilbene, safflower, pearl, has effects that blood-activating and qi-promoting, treating chloasma and acne, achieves definite curative effect for treating chloasma,
And patient tolerability is good, but some patientss are not very obvious using rear curative effect or onset time is slow, it is therefore desirable to match to existing
Side is adjusted, and to shorten the time from medication to action, and improves treated effect.
Summary of the invention
The object of the present invention is to provide a kind of preparation methods of skin maintenance and cosmetic benefits freckle-diminishing capsule, and present invention employs vapor steamings
Evaporate the safflower of method extraction and the volatile oil of azalea, the raising significant in efficacy of prepared freckle-diminishing capsule.
The preparation method of freckle-diminishing capsule provided by the present invention, includes the following steps:
(1) mixture for using ethanol water refluxing extraction root of kirilow rhodiola, the fleece-flower root and Radix Angelicae Sinensis at least three times, merges and extracts
Liquid, filtering, recycling ethyl alcohol obtain solution;
(2) using the mixture of steam distillation processing safflower and azalea, volatile oil and the dregs of a decoction are obtained;
(3) dregs of a decoction that step (2) obtains are merged with fructus lycii and Radix Astragali, adds water to cook at least three times, merges and decoct
Liquid filters to get filtrate;
(4) filtrate that step (3) obtains is merged with the solution that step (1) obtains, is condensed into thick paste;
(5) by crushing pearl at pearl powder;
(6) thick paste that step (4) obtains and the pearl powder that step (5) obtain are mixed, then after drying
Crushing obtains fine powder;
(7) fine powder that step (6) obtains and the volatile oil that step (2) obtain are mixed, are packed into capsule to obtain the final product;
The quality proportioning for preparing each raw material of the freckle-diminishing capsule is as follows:
The quality proportioning of each raw material of the freckle-diminishing capsule is specially
In above-mentioned preparation method, in step (1), in the ethanol water volumn concentration of ethyl alcohol be 65%~
75%, such as 70%.
In above-mentioned preparation method, in step (1), the condition of the ethanol water refluxing extraction is as follows:
Three times using mixture described in the ethanol water refluxing extraction;
The condition extracted for the first time is as follows: using the ethanol water refluxing extraction 1~6 hour of 4~8 times of volumes,
Such as use the ethanol water refluxing extraction 3 hours of 6 times of volumes;
Second of condition extracted is as follows: using the ethanol water refluxing extraction 1~3 hour of 2~6 times of volumes,
Such as use the ethanol water refluxing extraction 2 hours of 4 times of volumes;
The condition that third time is extracted is as follows: the ethanol water refluxing extraction 0.5~1.5 using 2~6 times of volumes is small
When, such as use the ethanol water refluxing extraction 1 hour of 4 times of volumes.
In above-mentioned preparation method, in step (2), the steam distillation includes the following steps:
The safflower and the azalea crushed 50 meshes, then obtain Aqueous extracts using water refluxing extraction;Using just
Hexane extracts the Aqueous extracts, obtains water phase and organic phase, and the organic phase is the transparent oily liquid with aromatic odor, warp
It is drying to obtain the volatile oil;The dregs of a decoction are obtained by filtration in the water phase;
The condition of the refluxing extraction is as follows:
Using the water refluxing extraction 3~7 hours of 4~8 times of volumes, the water refluxing extraction 5 of 6 times of volumes is such as used
Hour;
Anhydrous sodium sulfate can be used to be dried.
In above-mentioned preparation method, in step (3), the condition of the decoction is as follows:
It is decocted three times using water;
The condition decocted for the first time is as follows: being decocted 1~5 hour using the water of 4~8 times of volumes, such as uses the water of 6 times of volumes
It decocts 3 hours;
Second of condition decocted is as follows: being decocted 1~3 hour using the water of 2~6 times of volumes, such as uses the water of 4 times of volumes
It decocts 2 hours;
The condition that third time decocts is as follows: being decocted 0.5~1.5 hour using the water of 2~6 times of volumes, such as uses 4 times of volumes
Water decoct 1 hour.
In above-mentioned preparation method, in step (4), the relative density of the thick paste is 1.30~1.35 (50 DEG C).
In above-mentioned preparation method, in step (5), the partial size of the pearl powder is 70~80 μm (200 mesh).
In above-mentioned preparation method, in step (6), the condition of the drying is as follows:
Using micro-wave vacuum method, in low firepower, first 13 minutes are intermittent heating (open and stop for 1 minute 1 minute), later
For laser heating, 24 DEG C~39 DEG C of temperature are controlled, vacuum degree -0.084MPa.
The partial size of the fine powder is 70~80 μm (200 mesh).
The preparation method of skin maintenance and cosmetic benefits freckle-diminishing capsule provided by the invention, compared with former preparation method, advantage and feature exist
In:
(1) with safflower and azalea instead of the radix rehmanniae recen and Rehmannia glutinosa in original formulation.Safflower has blood circulation, stagnation resolvation
It relieves pain, the function of promoting blood circulation and detoxication, for treating the diseases such as dysmenorrhea, traumatic injury, arthralgia, coronary heart disease.Azalea contains Huang
The effective components such as ketone, Diterpenes have the effects that antibechic, eliminating the phlegm, relieving asthma, is anti-inflammatory, analgesia, additionally to cardiovascular, nerve
System plays a variety of effects.
(2) it is used as medicine with safflower and Du Juan volatile oil, further shortens the drug effect time, and it is effective to improve treatment
Rate.Flos Carthami volatile oil has identified 48 kinds of volatile chemical components, including 7,9- docosane ketone, caryophyllene oxide at present
Deng, by construct disease network model find these ingredients in the treatment of the diseases such as tumour, cirrhosis, hyperlipidemia, myocardial ischemia
In play a significant role.Cuckoo flowers volatile oil has identified 62 kinds of volatile components at present, it is known that wherein δ-cadinene, γ-Du
Loose alkene, bulnesol and α-cadinol have phlegm-dispelling functions, and guaiol and bulnesol have antitussive effect.
Specific embodiment
Experimental method used in following embodiments is conventional method unless otherwise specified.
The materials, reagents and the like used in the following examples is commercially available unless otherwise specified.
Embodiment 1,
Each component is weighed according to the following recipe:
It is prepared by the following method:
1) by root of kirilow rhodiola, the fleece-flower root, Radix Angelicae Sinensis with 70% ethanol water (volume) refluxing extraction three times, for the first time using use
The ethyl alcohol that 6 times of medicinal material volume extracts 3 hours, is extracted 2 hours using 4 times of medicinal material volume of ethyl alcohol for the second time, uses medicine for the third time
The ethyl alcohol that 4 times of material volume extracts 1 hour, combined extract, filtration, recycles ethyl alcohol, and acquired solution is spare;
2) using steam distillation processing safflower and azalea, dry safflower 80g and azalea 200g are taken, with common
Pulverizer crushes and crosses 50 meshes, is then uniformly mixed, and is boiled refluxing extraction 5 hours with the boiling of 6 times of volumes, is extracted using n-hexane
Water intaking extract obtains water phase and organic phase, and the organic phase is the transparent oily liquid with aromatic odor, waves through being drying to obtain
Hair oil;Water phase is through being obtained by filtration the dregs of a decoction.
3) dregs of a decoction that step 2) obtains are merged with fructus lycii, Radix Astragali, is added water to cook three times, use medicinal material volume for the first time
6 times of water decocts 3 hours, is decocted 2 hours using 4 times of medicinal material volume of water for the second time, uses 4 times of medicinal material volume of water for the third time
It decocts 1 hour, collecting decoction filters to obtain filtrate.
4) filtrate obtained by step 3) is merged with step 1) acquired solution, being concentrated into relative density is 1.30~1.35 (50
DEG C) thick paste it is spare;
5) by sieve after crushing pearl at fine powder, partial size is 70 μm~80 μm (200 mesh);
6) it by thick paste that step 4) obtains and the fine powder that step 5) obtains, mixes, micro-wave vacuum (low fire in use
Power, first 13 minutes are intermittent heating, open and stop within 1 minute 1 minute, are later laser heating, control 24 DEG C -39 DEG C of temperature, vacuum
Degree -0.084MPa.), it is ground into fine powder, granularity is 70 μm~80 μm (200 mesh);
7) fine powder for obtaining step 6) sprays the volatile oil as made from step 2), mixes, and is packed into capsule to obtain the final product.
Comparative example 1,
Each component is weighed according to the following recipe:
It is prepared by the following method:
1) root of kirilow rhodiola, the fleece-flower root and Radix Angelicae Sinensis (are used for the first time three times with 70% ethanol water (volume) refluxing extraction
It is extracted 3 hours with 6 times of medicinal material volume of 70% ethyl alcohol, is extracted 2 hours using 4 times of medicinal material volume of 70% ethyl alcohol for the second time, the
Extracted 1 hour using 4 times of medicinal material volume of 70% ethyl alcohol three times), merge extracting solution three times, ethyl alcohol is recovered under reduced pressure, is condensed into cream,
Dry, to be ground into fine powder spare, partial size is 70 μm~80 μm (200 mesh);
2) fructus lycii, radix rehmanniae recen, Rehmannia glutinosa and Radix Astragali boiling (are decocted 3 using 6 times of medicinal material volume of water for the first time three times
Hour, decocted 2 hours using 4 times of medicinal material volume of water, decocted 1 hour using 4 times of medicinal material volume of water for the third time for the second time),
Merge that extracting solution filtering three times, concentration, (low firepower in use, first 13 minutes are intermittent heating to micro-wave vacuum, open 1 point
Clock stops 1 minute, is later laser heating, controls 24 DEG C~39 DEG C of temperature, vacuum degree -0.084MPa.) fine powder is obtained, partial size is 70 μ
M~80 μm (200 mesh);
3) by sieve after crushing pearl at fine powder, granularity is 70 μm~80 μm (200 mesh);
4) add auxiliary material to mix well fine powder obtained by step 1), step 2) and step 3), sterilize, dosing is filled with starch supplementary material
It is encapsulated to obtain the final product.
The capsule that embodiment 1 and comparative example 1 are prepared respectively is used for clinic by embodiment 2, and to it for original disease
Curative effect is compared
In order to compare with brilliant pearl freckle-diminishing capsule today of brilliant pearl stonecrop spot removal capsule prepared by the present invention and original method preparation
Curative effect, the brilliant pearl hospital of traditional Chinese hospital, Beijing is included in 120 patient with chloasma, and is randomly divided into A group and B group, each 60.Wherein A group
The brilliant pearl stonecrop spot removal for using original method to prepare using brilliant pearl stonecrop spot removal capsule for treating (embodiment 1) prepared by the present invention, B group
Capsule for treating (comparative example 1).Two groups be 2 times a day, one time 4,3 months are as a treatment course.
Curative effect determinate standard are as follows: calculated and integrated with the sum of skin lesion area and skin color score.Skin lesion area scoring: area
≤5cm21 point is obtained, 5cm2< area≤10cm22 points are obtained, area > 10cm2Obtain 3 points;Skin color scoring: it is light brown to obtain 1 point,
Dark brown obtains 2 points, and dark brown obtains 3 points.
Therapeutic index (%)=(total mark after total mark-treatment before treating)/total mark × 100% before treating.Curative effect refers to
Number > 90% be cure, therapeutic index 60%~90% be it is effective, therapeutic index 30%~59% be progress, therapeutic index <
30% is invalid.The time that onset time=from starting medication therapeutic index is 30%.Total effective rate=(recovery from illness number of cases+aobvious
Imitate number of cases)/total number of cases × 100%, total effective rate=(recovery from illness number of cases+effective number of cases+effective number of cases)/total number of cases × 100%.
Two groups of average onset times and Comparison of therapeutic are as shown in table 1.
The average onset time of two groups of table 1 A, B and Comparison of therapeutic
By the data in table 1 it is found that the average onset time of A group is only (12.7 ± 3.2) day, considerably shorter than B group
(28.5 ± 2.6) day (P < 0.05) shows to work faster with brilliant pearl stonecrop spot removal capsule prepared by the present invention, this is for patient
Treatment confidence is established, enhancing curative compliance is of great significance.
In addition, two groups of A, B of total effective rate is respectively 86.6% and 80.0%, statistical significance (P > is had not yet been reached in difference
0.05), but the obvious effective rate of A group is 60.0%, and significantly larger than 36.6% (P < 0.05) of B group, this shows with prepared by the present invention
Its obvious effective rate of brilliant pearl stonecrop spot removal capsule is better than the brilliant pearl stonecrop spot removal capsule of original method preparation, and the latter's treatment results are only presented
Progressive accounting is higher.
In terms of adverse reaction, A group and B group respectively have 1 of short duration gastrointestinal reaction occur, but are slightly, not influence to control
It treats, and completes the treatment of a course for the treatment of.
The capsule that embodiment 1 and comparative example 1 are prepared respectively is used for clinic by embodiment 3, and to it for new indication
Curative effect is compared
The brilliant pearl hospital of traditional Chinese hospital, Beijing is in the process for being used for chloasma treatment with brilliant pearl stonecrop spot removal capsule prepared by the present invention
In, it is found that the medicine also has curative effect to the female patient of qi stagnation and blood stasis type primary dysmenorrhea, therefore has carried out preliminary observation to this.It will
60 qi stagnation and blood stasis type primary dysmenorrhea patient 60 are randomly divided into treatment group and control group, and every group each 30.Treatment group uses
With brilliant pearl stonecrop spot removal capsule for treating prepared by the present invention, control group is controlled using the brilliant pearl stonecrop spot removal capsule of original method preparation
It treats, treats 3 months altogether, observe curative effect and pretherapy and post-treatment visual analogue scale (VAS).
Two groups of curative effects are more as shown in table 2, and pretherapy and post-treatment VAS scoring is as shown in table 3.
The Clinical efficacy comparison of table 2 treatment group and control group
Group | Number of cases | Recovery from illness | It is effective | In vain | Total effective rate |
Treatment group | 30 | 15 | 10 | 5 | 83.3% |
Control group | 30 | 6 | 12 | 12 | 60.0% |
VAS scoring is compared before and after treatment for 3 treatment group of table and control group
Note: compared with * is preceding with group treatment, P < 0.05;# is compared with after control group treatment, P < 0.05.
Due to being preliminary observation, therefore placebo group is not set.But from the above still as it can be seen that crystalline substance prepared by the present invention
Pearl stonecrop spot removal capsule, total effective rate 83.3% are significantly higher than the brilliant pearl stonecrop spot removal capsule (60.0%) of original method preparation,
It is also significantly improved to pretherapy and post-treatment VAS scoring simultaneously, and better than the brilliant pearl stonecrop spot removal capsule of original method preparation.
Brilliant pearl stonecrop spot removal capsule prepared by the present invention is main to become compared with brilliant pearl stonecrop spot removal capsule prepared by original method
Change is with safflower and azalea instead of the radix rehmanniae recen and Rehmannia glutinosa in original method, and is extracted with steam distillation red
Colored and azalea volatile oil.
Claims (7)
1. a kind of preparation method of freckle-diminishing capsule, includes the following steps:
(1) using ethanol water refluxing extraction root of kirilow rhodiola, the fleece-flower root and Radix Angelicae Sinensis mixture at least three times, combined extract,
Filtering, recycling ethyl alcohol obtain solution;
(2) using the mixture of steam distillation processing safflower and azalea, volatile oil and the dregs of a decoction are obtained;
(3) dregs of a decoction that step (2) obtains are merged with fructus lycii and Radix Astragali, is added water to cook at least three times, collecting decoction, mistake
Filter to obtain filtrate;
(4) filtrate that step (3) obtains is merged with the solution that step (1) obtains, is condensed into thick paste;
(5) by crushing pearl at pearl powder;
(6) thick paste that step (4) obtains and the pearl powder that step (5) obtain are mixed, is then crushed after drying
Obtain fine powder;
(7) fine powder that step (6) obtains and the volatile oil that step (2) obtain are mixed, are packed into capsule to obtain the final product;Preparation
The quality proportioning of each raw material of the freckle-diminishing capsule is as follows:
2. preparation method according to claim 1, it is characterised in that: in step (1), ethyl alcohol in the ethanol water
Volumn concentration is 65%~75%.
3. preparation method according to claim 1 or 2, it is characterised in that: in step (1), the ethanol water reflux
The condition of extraction is as follows:
Three times using mixture described in the ethanol water refluxing extraction;
The condition extracted for the first time was as follows: using the ethanol water refluxing extraction 1~5 hour of 4~8 times of volumes;
Second of condition extracted was as follows: using the ethanol water refluxing extraction 1~4 hour of 2~6 times of volumes;
The condition that third time is extracted was as follows: using the ethanol water refluxing extraction 0.5~1.5 hour of 2~6 times of volumes.
4. preparation method according to any one of claim 1-3, it is characterised in that: in step (2), the vapor steams
The method of evaporating includes the following steps:
Then the safflower and the azalea obtain Aqueous extracts using water refluxing extraction through pulverizing and sieving;Using n-hexane extraction
The Aqueous extracts obtain water phase and organic phase, and the organic phase is transparent oily liquid, are drying to obtain the volatile oil;Institute
It states water phase and the dregs of a decoction is obtained by filtration.
5. preparation method described in any one of -4 according to claim 1, it is characterised in that: in step (3), the item of the decoction
Part is as follows:
It is decocted three times using water;
The condition decocted for the first time is as follows: being decocted 1~5 hour using the water of 4~8 times of volumes;
Second of condition decocted is as follows: being decocted 1~4 hour using the water of 2~6 times of volumes;
The condition that third time decocts is as follows: being decocted 0.5~1.5 hour using the water of 2~6 times of volumes.
6. preparation method according to any one of claims 1-5, it is characterised in that: in step (5), the pearl powder
Partial size is 70~80 μm.
7. preparation method according to claim 1 to 6, it is characterised in that: in step (6), the item of the drying
Part is as follows:
Using micro-wave vacuum method, in low firepower, it is later laser heating that first 13 minutes, which are intermittent heating, controls temperature
It is 24 DEG C~39 DEG C, vacuum degree is -0.084MPa.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111343075.6A CN114288231A (en) | 2018-11-21 | 2018-11-21 | Preparation method of capsule for beautifying and removing freckles |
CN201811391289.9A CN109303758A (en) | 2018-11-21 | 2018-11-21 | A kind of preparation method of skin maintenance and cosmetic benefits freckle-diminishing capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811391289.9A CN109303758A (en) | 2018-11-21 | 2018-11-21 | A kind of preparation method of skin maintenance and cosmetic benefits freckle-diminishing capsule |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111343075.6A Division CN114288231A (en) | 2018-11-21 | 2018-11-21 | Preparation method of capsule for beautifying and removing freckles |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109303758A true CN109303758A (en) | 2019-02-05 |
Family
ID=65222293
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811391289.9A Pending CN109303758A (en) | 2018-11-21 | 2018-11-21 | A kind of preparation method of skin maintenance and cosmetic benefits freckle-diminishing capsule |
CN202111343075.6A Pending CN114288231A (en) | 2018-11-21 | 2018-11-21 | Preparation method of capsule for beautifying and removing freckles |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111343075.6A Pending CN114288231A (en) | 2018-11-21 | 2018-11-21 | Preparation method of capsule for beautifying and removing freckles |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN109303758A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1733141A (en) * | 2005-08-17 | 2006-02-15 | 师宇 | New preparation for curing chloasma and acne |
CN1931282A (en) * | 2006-09-26 | 2007-03-21 | 兰玉岐 | Chinese medicine composition for promoting blood circulation to eliminate spots and its prepn process |
CN101485782A (en) * | 2008-01-16 | 2009-07-22 | 北京天科仁祥医药科技有限公司 | Chinese medicinal composition for dissolving stasis and eliminating plaque and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005060308A (en) * | 2003-08-13 | 2005-03-10 | National Institute Of Advanced Industrial & Technology | Agent for enhancing and promoting production of adiponectin |
CN106728651B (en) * | 2017-03-16 | 2020-10-30 | 南京中医药大学 | Preparation method and quality detection method of rhizoma cyperi four-ingredient granules |
-
2018
- 2018-11-21 CN CN201811391289.9A patent/CN109303758A/en active Pending
- 2018-11-21 CN CN202111343075.6A patent/CN114288231A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1733141A (en) * | 2005-08-17 | 2006-02-15 | 师宇 | New preparation for curing chloasma and acne |
CN1931282A (en) * | 2006-09-26 | 2007-03-21 | 兰玉岐 | Chinese medicine composition for promoting blood circulation to eliminate spots and its prepn process |
CN101485782A (en) * | 2008-01-16 | 2009-07-22 | 北京天科仁祥医药科技有限公司 | Chinese medicinal composition for dissolving stasis and eliminating plaque and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
杨俊杰等: "《中药化学实用技术》", 29 February 2016, 重庆大学出版社 * |
Also Published As
Publication number | Publication date |
---|---|
CN114288231A (en) | 2022-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101513437B (en) | Antifatigue Chinese pharmaceutical composition and preparation method thereof | |
JP2001514650A (en) | Essential oil composition | |
EP3295949B1 (en) | Topical drug for treating breast cancer and preparation method thereof | |
CN104013929B (en) | Rheumatism pain relief medicine for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof | |
CN102225100A (en) | Chinese medicinal formulation for treating cardiovascular and cerebrovascular diseases and preparation process of products thereof | |
CN108815298A (en) | A kind of blood-head poison stops up psoriasis pustulosa treatment formula and preparation method | |
CN101991814A (en) | Preparation with functions of expelling wind, reducing phlegm, promoting blood circulation and removing obstruction from channels and preparation method | |
CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
CN104606628A (en) | Face-nourishing, beautifying and chloasma-removing traditional Chinese medicine composition | |
CN109303758A (en) | A kind of preparation method of skin maintenance and cosmetic benefits freckle-diminishing capsule | |
CN108186852A (en) | Pharmaceutical composition for anti-treating caput femoris necrosis and preparation method thereof | |
CN102397470A (en) | Beautifying spot-removing cream and preparation method thereof | |
CN105362630A (en) | Climacteric syndrome treatment pharmaceutical composition and preparation method thereof | |
CN102091254B (en) | Traditional Chinese medicine composition for relieving swelling after cosmetic surgery and preparation method thereof | |
CN1060349C (en) | Menstruation-regulating and speckle-removing capsule and preparation thereof | |
CN104056017A (en) | Traditional Chinese medicine composition for treating rheumatism and preparation method thereof | |
CN108371656A (en) | The preparation method of six ingredients containing rehmanniae drop pill | |
CN104547474B (en) | A kind of purposes of Chinese medicine preparation in treatment liver-cancer medicine is prepared | |
CN103006836A (en) | Preparation method of drug capable of promoting blood circulation to remove blood stasis and promoting qi circulation to relieve pains | |
CN107875288A (en) | Preparation method with promoting blood circulation, the Chinese medicine composition of beauty functions and its granule | |
CN105797068A (en) | Application of traditional Chinese medicine preparation in preparation of medicine for treating heel pains through external application | |
CN1733191A (en) | Capsule for warming uterus and promoting pregnancy and process for preparing the same | |
CN105497783A (en) | Application of traditional Chinese medicine preparation to preparing drug for treating qi stagnation and blood stasis type chloasma | |
CN1175461A (en) | Medicine composition for treating cardiovascular and cerebrovascular diseases and preparing process thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190205 |